Hainan Poly Pharm Co Ltd
SZSE:300630
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hainan Poly Pharm Co Ltd
SZSE:300630
|
CN |
|
Z
|
Zhongchang International Holdings Group Ltd
HKEX:859
|
HK |
|
C
|
China ZhengTong Auto Services Holdings Ltd
HKEX:1728
|
CN |
|
S
|
Sigachi Industries Ltd
NSE:SIGACHI
|
IN |
|
S
|
Shaoyang Victor Hydraulics Co Ltd
SZSE:301079
|
CN |
|
Cannae Holdings Inc
NYSE:CNNE
|
US |
|
Medios AG
XETRA:ILM1
|
DE |
|
T
|
Tuticorin Alkali Chemicals and Fertilizers Ltd
BSE:506808
|
IN |
|
Splendid Medien AG
XETRA:SPM
|
DE |
|
China Merchants Port Group Co Ltd
SZSE:001872
|
CN |
|
China High Speed Railway Technology Co Ltd
SZSE:000008
|
CN |
Hainan Poly Pharm Co Ltd
Hainan Poly Pharm.Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 1,221 full-time employees. The company went IPO on 2017-03-28. The firm operates five segments. The Anti-Allergic segment is engaged in the production of desloratadine dispersible tablets, desloratadine dry suspension and desloratadine tablets. The Antibiotic segment provides levofloxacin hydrochloride capsules and azithromycin dry suspension for the treatment of bacterial infections. The Nonsteroidal Anti-inflammatory Drugs segment provides diclofenac sodium enteric-coated sustained-release capsule products for the treatment of arthritis and dysmenorrhea. The Digestive segment is involved in providing trimebutine maleate tablets to treat abdominal pain, diarrhea, and irritable bowel syndrome. The firm also operates Other segment.
Hainan Poly Pharm.Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 1,221 full-time employees. The company went IPO on 2017-03-28. The firm operates five segments. The Anti-Allergic segment is engaged in the production of desloratadine dispersible tablets, desloratadine dry suspension and desloratadine tablets. The Antibiotic segment provides levofloxacin hydrochloride capsules and azithromycin dry suspension for the treatment of bacterial infections. The Nonsteroidal Anti-inflammatory Drugs segment provides diclofenac sodium enteric-coated sustained-release capsule products for the treatment of arthritis and dysmenorrhea. The Digestive segment is involved in providing trimebutine maleate tablets to treat abdominal pain, diarrhea, and irritable bowel syndrome. The firm also operates Other segment.
